As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Clinical Trials Market: By Material: Plastic, Glass, Metal, Paper, Corrugated Fibre, Others; By Product: Vials and Ampoules, Syringes, Tubes, Bottles, Others; By Application; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments

Global Clinical Trials Market Outlook

The global clinical trials market attained a value of USD 44.3 billion in 2021. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 5.4% to reach USD 60.7 billion by 2026.

 

Increasing Demand for Oncology to Augment the Clinical Trials Industry Growth

Oncology clinical trials are more complex than other therapeutic disciplines since they require advanced treatments for specific malignancies. An oncology trial looks not only into the efficacy and safety of an antibiotic against infection, but also how it can improve the subject's quality of life. Because cancer research is growing at a quick rate, immunotherapy has shifted away from chemotherapy procedures and toward molecularly targeted medicines. The evolution of oncology clinical trials has seen rapid development in available clinical data, as well as a strong and rising pipeline of therapeutic candidates.

 

Global Clinical Trials Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to Provide Significant Growth Opportunities to the Clinical Trial Industry

Geographically, North America accounts for a dominant share in the industry owing to large investment for outsourcing the big R&D companies. This is mainly due to the major demand for investments in drug development. Due to the rising COVID-19 cases, many big R&D firms have collaborated with government and non-government organisations to manufacture therapeutic drug injections. The United States is one of the largest global manufacturers of clinical trials as they are investing more in R&D development. Meanwhile, the Asia Pacific is expected to witness a robust growth in the forecast period due to the increasing focus of manufacturers to produce vaccines to decrease death risk due to the COVID-19 pandemic.

 

Clinical Trials: Industry Definition and Segmentation

Clinical trials are research studies that are used to assess the effectiveness of a medicinal, surgical, or behavioural intervention. They are the primary method by which scientists determine whether a new treatment, such as a new medicine, diet, or medical instrument, is safe and effective in humans. A clinical trial is frequently performed to determine whether a new medication is more effective and has fewer negative side effects.

By design, the market is divided into:

  • Treatment Studies
    • Randomised Control Trial
    • Adaptive Clinical Trail
    • Non- Randomised Control Trial
  • Observational Studies
    • Cohort Studies
    • Case Control Study
    • Cross Section Study
    • Ecological Study
    • Others

The regional markets for clinical trials include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Increasing Focus on Therapeutic Drugs Generation to Bolster the Growth of Clinical Trials Industry

The global clinical trial industry is being driven by the increasing demand for the production of therapeutic drugs across the globe. Due to the COVID-19 pandemic, significant changes in the clinical trials industry has shifted the central point of many research and commercial companies to give attention on the development of new therapeutic drugs and vaccines for COVID-19. The industry is also predicted to develop as a result of government initiatives in emerging nations to promote medication discovery and constant technical advances. Over the forecast period, it can be expected that Phase III will grow and become significant as it is one of the most important stages in determining whether or not a new intervention is effective and useful for clinical purposes.

 

Key Industry Players in the Global Clinical Trials Market

The report presents a detailed analysis of the following key players in the global clinical trials market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • IQVIA
  • Parexel International Corporation
  • Charles River laboratory
  • ICON Plc
  • Syneos Health 
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Design, Region
Breakup by Design Treatment Studies, Observational Studies
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered IQVIA, PAREXEL International Corporation, Charles River Laboratory, ICON Plc, Syneos Health, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface           
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Clinical Trials Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Clinical Trials Historical Market (2017-2021) 
    8.3    Global Clinical Trials Market Forecast (2022-2027)
    8.4    Global Clinical Trials Market by Design
        8.4.1    Treatment Studies
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Treatment Studies Type
                8.4.1.4.1    Randomised Control Trial
                    8.4.1.4.1.1    Market Share
                    8.4.1.4.1.2    Historical Trend (2017-2021)
                    8.4.1.4.1.3    Forecast Trend (2022-2027)
                8.4.1.4.2    Adaptive Clinical Trail
                    8.4.1.4.2.1    Market Share
                    8.4.1.4.2.2    Historical Trend (2017-2021)
                    8.4.1.4.2.3    Forecast Trend (2022-2027)
                8.4.1.4.3    Non- Randomised Control Trial
                    8.4.1.4.3.1    Market Share
                    8.4.1.4.3.2    Historical Trend (2017-2021)
                    8.4.1.4.3.3    Forecast Trend (2022-2027)
        8.4.2    Observational Studies
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Observational Studies Type
                8.4.2.4.1    Cohort Studies
                    8.4.2.4.1.1    Market Share
                    8.4.2.4.1.2    Historical Trend (2017-2021)
                    8.4.2.4.1.3    Forecast Trend (2022-2027)
                8.4.2.4.2    Case Control Study
                    8.4.2.4.2.1    Market Share
                    8.4.2.4.2.2    Historical Trend (2017-2021)
                    8.4.2.4.2.3    Forecast Trend (2022-2027)
                8.4.2.4.3    Cross Section Study
                    8.4.2.4.3.1    Market Share
                    8.4.2.4.3.2    Historical Trend (2017-2021)
                    8.4.2.4.3.3    Forecast Trend (2022-2027)
                8.4.2.4.4    Ecological Study
                    8.4.2.4.4.1    Market Share
                    8.4.2.4.4.2    Historical Trend (2017-2021)
                    8.4.2.4.4.3    Forecast Trend (2022-2027)
                8.4.2.4.5    Others
    8.5    Global Clinical Trials Market by Region
        8.5.1    Market Share
            8.5.1.1    North America
            8.5.1.2    Europe
            8.5.1.3    Asia Pacific
            8.5.1.4    Latin America
            8.5.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1     IQVIA    
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    PAREXEL International Corporation
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Charles River Laboratory
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    ICON Plc
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Syneos Health 
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Clinical Trials Market: Key Industry Highlights, 2016 and 2026
2.    Global Clinical Trials Historical Market: Breakup by Phase (USD Billion), 2017-2021
3.    Global Clinical Trials Market Forecast: Breakup by Phase (USD Billion), 2022-2027
4.    Global Clinical Trials Historical Market: Breakup by Study Design (USD Billion), 2017-2021
5.    Global Clinical Trials Market Forecast: Breakup by Study Design (USD Billion), 2022-2027
6.    Global Clinical Trials Historical Market: Breakup by Indication (USD Billion), 2017-2021
7.    Global Clinical Trials Market Forecast: Breakup by Indication (USD Billion), 2022-2027
8.    Global Clinical Trials Historical Market: Breakup by Indication by Study Design (USD Billion), 2017-2021
9.    Global Clinical Trials Market Forecast: Breakup by Indication by Study Design (USD Billion), 2022-2027
10.    Global Clinical Trials Historical Market: Breakup by Region (USD Billion), 2017-2021
11.    Global Clinical Trials Market Forecast: Breakup by Region (USD Billion), 2022-2027
12.    North America Clinical Trials Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    North America Clinical Trials Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Europe Clinical Trials Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Europe Clinical Trials Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Asia Pacific Clinical Trials Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Asia Pacific Clinical Trials Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Latin America Clinical Trials Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Latin America Clinical Trials Market Forecast: Breakup by Country (USD Billion), 2022-2027
20.    Middle East and Africa Clinical Trials Historical Market: Breakup by Country (USD Billion), 2017-2021
21.    Middle East and Africa Clinical Trials Market Forecast: Breakup by Country (USD Billion), 2022-2027
22.    Global Clinical Trials Market Structure

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER